Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2971746 | The Journal of Heart and Lung Transplantation | 2009 | 5 Pages |
Abstract
Outcomes in EIS and PVS patients undergoing lung transplantation compare favorably to that of all pediatric lung transplant recipients (median survival 4.3 years). For PA patients, their underlying pathology appears to make them high-risk candidates for lung transplantation. For the younger and acutely sicker PVS patients, lung transplantation is a viable therapeutic alternative.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
R. Mark MD, Sanjiv MD, Stuart C. MD, Jingnan MS, Charles B. MD,